ID: ALA4561411

Max Phase: Preclinical

Molecular Formula: C30H32Cl2F3N7O5

Molecular Weight: 584.51

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  CN(C)CC/C=C/C(=O)Nc1ccc(N2CC[C@@H](NC(=O)c3n[nH]cc3NC(=O)c3c(Cl)cccc3Cl)C2)cc1.O=C(O)C(F)(F)F

Standard InChI:  InChI=1S/C28H31Cl2N7O3.C2HF3O2/c1-36(2)14-4-3-8-24(38)32-18-9-11-20(12-10-18)37-15-13-19(17-37)33-28(40)26-23(16-31-35-26)34-27(39)25-21(29)6-5-7-22(25)30;3-2(4,5)1(6)7/h3,5-12,16,19H,4,13-15,17H2,1-2H3,(H,31,35)(H,32,38)(H,33,40)(H,34,39);(H,6,7)/b8-3+;/t19-;/m1./s1

Standard InChI Key:  SXGSVRQWHVYATD-FGTSTTERSA-N

Associated Targets(Human)

Cyclin-dependent kinase 14/Cyclin-Y 136 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

HCT-116 91556 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 584.51Molecular Weight (Monoisotopic): 583.1865AlogP: 4.42#Rotatable Bonds: 10
Polar Surface Area: 122.46Molecular Species: BASEHBA: 6HBD: 4
#RO5 Violations: 1HBA (Lipinski): 10HBD (Lipinski): 4#RO5 Violations (Lipinski): 1
CX Acidic pKa: 10.75CX Basic pKa: 9.45CX LogP: 4.47CX LogD: 2.59
Aromatic Rings: 3Heavy Atoms: 40QED Weighted: 0.26Np Likeness Score: -1.55

References

1. Ferguson FM, Doctor ZM, Ficarro SB, Marto JA, Kim ND, Sim T, Gray NS..  (2019)  Synthesis and structure activity relationships of a series of 4-amino-1H-pyrazoles as covalent inhibitors of CDK14.,  29  (15): [PMID:31175010] [10.1016/j.bmcl.2019.05.024]

Source